Softeron 50 Capsule

Docusate Sodium
50mg
Aristo Pharmaceuticals Ltd.
Pack size
Dispensing mode
Source
Agent
Retail Price

Indications

Softeron 50 Capsule is used for: Constipation

Adult Dose

Oral Constipation Adult: 1 tablet daily at bed time

Child Dose

Oral Constipation Child: 6-12 yr: 40-120 mg/day; 3-6 yr: 20-60 mg/day. To be given in divided doses.

Renal Dose

Administration

Contra Indications

Intestinal obstruction or undiagnosed abdominal symptoms. Prolonged use. Concurrent use with liqd paraffin.

Precautions

Pregnancy, lactation. Lactation: Unknown whether drug is excreted in milk; compatible with nursing

Pregnancy-Lactation

Interactions

Enhances GI uptake of other drugs. Increases effect of anthraquinone laxatives. Increases incidence of adverse effects when given concurrently with aspirin.

Adverse Effects

Side effects of Docusate Sodium : Abdominal cramping,Diarrhea,Excessive bowel activity,Intestinal obstruction,Throat irritation

Mechanism of Action

Docusate sodium is an anionic surfactant which is considered to act primarily by increasing the penetration of fluid into the faeces. It may also have other effects on intestinal fluid secretion, and may act both as stimulant and as faecal softening agent.

Note

Softeron 50 50mg Capsule manufactured by Aristo Pharmaceuticals Ltd.. Its generic name is Docusate Sodium. Softeron 50 is availble in Nepal. Farmaco Nepal drug index information on Softeron 50 Capsule is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Docusate Sodium :